Modified-release Gamma-Hydroxybutyrate – Cellets formulation
The patent application titled “Modified Release Gamma-Hydroxybutyrate (GHB) Formulations Having Improved Pharmacokinetics” (US20240148685) focuses on improving the delivery of GHB, a substance used for treating sleep disorders like narcolepsy, through modified-release formulations. The goal is to optimize GHB’s absorption, enhancing patient convenience and compliance by reducing the need for multiple nightly doses.
The key innovation in the patent is the use of CELLETS® , microcrystalline spheres often employed as a neutral core for drug layering. In this application, CELLETS® act as carriers for the active ingredient, allowing precise control over the release profile of GHB. These small spherical particles, made from microcrystalline cellulose, offer uniform size and high mechanical strength, ensuring consistent drug loading and a controlled release rate.
In this patent, the CELLETS® are coated with various layers of GHB and release-modifying agents, enabling a predictable and sustained release of the active substance. This modified release profile allows GHB to be administered in a once-nightly dose rather than requiring the patient to wake up for a second dose, which was a limitation with previous immediate-release formulations. This extended-release mechanism helps maintain stable plasma concentrations of GHB over an 8-hour period, improving both the efficacy of the treatment and patient compliance.
The innovation emphasizes addressing the shortcomings of existing GHB formulations by ensuring a better pharmacokinetic profile—particularly regarding absorption, bioavailability, and minimizing drug levels in the bloodstream after the therapeutic effect has been achieved. In this specific patent, the following MCC Sphere types are recommended: CELLETS® 90, CELLETS® 100, CELLETS® 127.
Read more here
Product Information
| Product, standard sizes | Size |
|---|---|
| Cellets 100 | 100-200 µm |
| Cellets 200 | 200-355 µm |
| Cellets 350 | 350-500 µm |
| Cellets 500 | 500-710 µm |
| Cellets 700 | 700-1000 µm |
| Cellets 1000 | 1000-1400 µm |
Source: ingredientpharm, website Modified-release Gamma-Hydroxybutyrate – Cellets formulation, https://cellets.com/portfolio-item/cellets/
You might also like:
- Patent on controlled release formulations of highly lipophilic physiologically active substances
- Patent on methods of administering gamma-hydroxybutyrate compositions with divalproex sodium
- Patent on modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
- Patent on extended-release compositions comprising atomoxetine
